secwatch / observer
8-K filed April 3, 2026, 7:59 PM ET ticker DMII CIK 0002040475
debt confidence high sentiment neutral materiality 0.60

DMIIU enters $1.4M convertible note agreement for de-SPAC financing; issues $300K interim note

Drugs Made In America Acquisition II Corp.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-039986
form_type
8-K
ticker
DMII
cik
0002040475
company_name
Drugs Made In America Acquisition II Corp.
filed_at
2026-04-03T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.437324+00:00
generated_at
2026-05-15T07:42:58.939353+00:00
sec_items
["1.01", "2.03", "9.01"]
event_type
debt
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-039986
json_url
https://secwatch.observer/filing/0001213900-26-039986.json
markdown_url
https://secwatch.observer/filing/0001213900-26-039986.md
text_url
https://secwatch.observer/filing/0001213900-26-039986.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/0001213900-26-039986-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea0285112-8k_drugs2.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

ffe25265d1f383b097c9a48cc37fc17841e15ed7

Drugs Made In America Acquisition II Corp. incurred convertible notes of $300,000 with Alpha Multi Family Office at does not bear interest maturing nine months from the date of issuance.

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

502c7ea63c715cfeff70ea23eb2799375e3612d9

Drugs Made In America Acquisition II Corp. entered into Interim Convertible Note with Alpha Multi Family Office valued at $300,000 Interim Convertible Note, convertible with 35% discount (effective 2026-03-30).

on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the " Second Note ").

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

75d6b4cb9b136192d0bf8b8b15092a28e8053f8c

Drugs Made In America Acquisition II Corp. entered into Definitive Investment and Sponsor Transition Agreement with Alpha Multi Family Office valued at $1,400,000 Convertible Notes Financing (effective 2026-03-24).

Effective March 24, 2026, the Company and the Investor entered into the Definitive Investment and Sponsor Transition Agreement (the " Agreement ") for the Convertible Notes Financing, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

TCPC

BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities

BlackRock TCP Capital Corp. June 1, 2026, 4:50 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

Item 1.01. Entry into a Material Definitive Agreement. On May 27, 2026 (the " Closing Date "), BlackRock TCP Capital Corp. (the " Company "), through its subsidiary, completed a $535,780,000 securitization of certain loans held by a subsidiary of the Company (the " CLO Transaction "). On the Closing Date and in connection with the CLO Transaction, BlackRock DLF 2026-C

Filing page SEC filing

EHC

Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028

Encompass Health Corp June 1, 2026, 4:26 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.

Filing page SEC filing

VVX

V2X refinances $868.5M term loans with new tranche maturing 2030; SOFR+2% margin

V2X, Inc. June 1, 2026, 4:10 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

The Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of $868,522,978.38 (the “New Term Loans”), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Amendment), as further set forth in the Amendment. The New Term Loans mature on December 6, 2030.

Filing page SEC filing

EMAT

EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued

Evolution Metals & Technologies Corp. May 11, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 7.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.

Filing page SEC filing

AZZ

AZZ refinances revolver; maturity extended to 2029, margins cut 50 bps

AZZ INC May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

The Seventh Amendment (i) terminated the Initial Revolving Credit Commitments and simultaneously replaced them in their entirety with Extended Revolving Credit Commitments having a Maturity Date of May 7, 2029, (ii) decreased the interest rate margin applicable to the Revolving Credit Loans from margins ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs) to margins ranging from 125 basis points to 225 basis points (subject to leverage ratio step-downs)

Filing page SEC filing

ILPT

ILPT Mountain JV closes $1.62B loan at 5.71% fixed, repays $1.6B existing debt

Industrial Logistics Properties Trust May 8, 2026, 7:59 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan . Also on May 8, 2026, we entered into a guaranty in favor of the lenders, pursuant to which we guaranteed certain limited

Filing page SEC filing

PGIM

PGIM Private Credit Fund enters $100M credit facility with $500M accordion option

PGIM Private Credit Fund May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

Repo Rate Average; and for Australian‐dollar advances, Bank Bill Swap Rate), in each case subject to a 0.25% floor. The initial facility amount of the Credit Facility is $100 million, with an accordion feature that permits increases, with the consent of the facility agent and the lenders, up to an aggregate commitment of $500 million. The Credit Facility has

Filing page SEC filing

LYV

Live Nation VenueCo closes €610M secured notes issuance backed by 4 venues

Live Nation Entertainment, Inc. May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).

Comparable filing

On May 8, 2026, Live Nation VenueCo, LLC (“VenueCo”), a bankruptcy-remote, special purpose vehicle owned by certain bankruptcy-remote, special purpose entities (the “Participants”), which are indirect subsidiaries of Live Nation Entertainment, Inc. (the “Company”), closed its previously announced issuance of €610 million aggregate principal amount of fixed rate senior secured notes (the “Notes”).

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-039986

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.